TRANSIDERM-NITRO

This brand name is authorized in Australia, Finland, Ireland, Netherlands, UK.

Active ingredients

The drug TRANSIDERM-NITRO contains one active pharmaceutical ingredient (API):

1	Glyceryl trinitrate UNII G59M7S0WS3 - NITROGLYCERIN
	Glyceryl trinitrate is a vasodilator and is used for angina of effort. Vasodilation is achieved by the releasing of free redical nitric oxide which activates guanylate cyclase and increases synthesis of guanosine 3′ and 5′-monophosphate with resultant effects on the phosphorylation of proteins in smooth muscle. If taken in excess, its vasodilatory effect can cause headache.
	Read more about Glyceryl trinitrate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TRANSIDERM NITRO Transdermal patch	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01DA02	Glyceryl trinitrate	C Cardiovascular system → C01 Cardiac therapy → C01D Vasodilators used in cardiac diseases → C01DA Organic nitrates
Discover more medicines within C01DA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1515R, 1516T
FI	Lääkealan turvallisuus- ja kehittämiskeskus	071950, 124509
GB	Medicines & Healthcare Products Regulatory Agency	140082, 146744, 146746, 162787, 162789, 18904, 18913, 382132
IE	Health Products Regulatory Authority	50040, 51261, 51544
NL	Z-Index G-Standaard, PRK	20672, 21520